5,176 transcripts
Page 32 of 100
ul
Earnings call transcript
NASDAQ
2024 Q2
6 Aug 24
and the comments made during this conference call and in the Risk Factors section of our Form 10-K, Form 10-Q and other reports and filings with the Securities
k6
Earnings call transcript
NASDAQ
2024 Q3
6 Aug 24
encourage you to review the company's filings with the SEC. This includes, without limitation, the company's Forms 10-K and 10-Q, which identify the specific
7s
Earnings call transcript
NYSE
2024 Q2
6 Aug 24
associated with the company's business, which are discussed in the company's filings with the Securities and Exchange Commission, including our 10-K
2f
Earnings call transcript
NYSE
2024 Q2
6 Aug 24
statements. These factors are discussed in our earnings release and in our Form 10-K and in other filings with the SEC. The company disclaims any
p5my
Earnings call transcript
NASDAQ
2024 Q2
6 Aug 24
earnings release and the risk factors of our most recent Form 10-K and 10-Q and other reports and filings we have made with the Securities
2v0
Earnings call transcript
NYSE
2024 Q2
6 Aug 24
with the SEC, including Form 10-K, 10-Q and 8-K.
ADC Therapeutics is providing this information as of today's date and does not undertake any obligation
c5
Earnings call transcript
NASDAQ
2024 Q2
6 Aug 24
recent annual report on Form 10-K and our other filings with the SEC.
On today's call, we will refer to adjusted EBITDA and adjusted EBITDA margin
so
Earnings call transcript
NYSE
2024 Q3
6 Aug 24
factors, MD&A and other sections of our annual report on Form 10-K and our other SEC filings. Additionally, we will be discussing certain non-GAAP
xhr
Earnings call transcript
NYSE
2024 Q2
6 Aug 24
of factors.
These factors are discussed in more detail in the company's filings with the SEC, including the company's most recent Form 10-K and Form 10
mm
Earnings call transcript
NYSE
2024 Q2
6 Aug 24
release issued this morning as well as our most recent quarterly report and annual report on Form 10-K which are available on the Investor Relations
rr24
Earnings call transcript
NASDAQ
2024 Q3
6 Aug 24
on Form 10-Q, annual results on Form 10-K, current reports on Form 8-K and those amendments thereto filed with the SEC and those mentioned
j6ua
Earnings call transcript
NYSE
2024 Q2
6 Aug 24
factors that could affect our actual results, please refer to our most recent quarterly report on Form 10-Q and our annual report on Form 10-K filed
jwz2
Earnings call transcript
NYSE
2024 Q2
6 Aug 24
factors discussed in our most recently filed Form 10-K for discussions of important risk factors that could cause actual results to differ materially
xrzn
Earnings call transcript
NASDAQ
2024 Q2
6 Aug 24
filed periodic reports on Form 10-K and 10-Q or any updates in our reports on Form 8-K filed with the U.S. Securities Exchange Commission
sq
Earnings call transcript
NASDAQ
2024 Q2
6 Aug 24
10-K for the year ended December 31, 2023, and in its other filings with the Securities and Exchange Commission.
Except as required by law, 908 Devices
t753
Earnings call transcript
NASDAQ
2024 Q2
6 Aug 24
and Exchange Commission, including Items 1A, Risk Factors, of the company's Form 10-K for the year ended December 31, 2023, and such factors may
n1
Earnings call transcript
NASDAQ
2024 Q2
6 Aug 24
such statements.
Factors that might cause such differences include, but are not limited to, those discussed in today's earnings release and in our Form 10-K
47kh
Earnings call transcript
NASDAQ
2024 Q2
6 Aug 24
and an amendment to our 2023 10-K that will be filed later this week. We are already in the process of updating our internal controls relative
30
Earnings call transcript
NASDAQ
2024 Q2
6 Aug 24
those set forth in the Risk Factors section of the company's Form 10-K for the year ended December 31, 2023, filed with the SEC. Copies of this document
n4
Earnings call transcript
NASDAQ
2025 Q1
6 Aug 24
statements, including all the risk factors, you can find them in our Forms 10-Q and 10-K and other documents that we file with the SEC, and they can